Microbix Expanding Addressable Market Share with Test Makers Augmenting its Recombinant Antigen Capabilities for Immunoassay Markets

MISSISSAUGA, Ontario, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces its intentions to broaden its platform capabilities to enable production of a wider range of test ingredients (“Antigens”) by using recombinant production technologies. Directing existing in-house synthetic biology capabilities to this project will create large-scale recombinant Antigens production to complement and expand Micr ...